{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:33:52Z","timestamp":1791441232569,"version":"4.3.3"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,14]],"date-time":"2012-04-14T00:00:00Z","timestamp":1334361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11011-012-9302-1","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T07:00:37Z","timestamp":1334300437000},"page":"121-129","source":"Crossref","is-referenced-by-count":54,"title":["Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms"],"prefix":"10.1007","volume":"27","author":[{"given":"Derbis","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Monaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,14]]},"reference":[{"key":"9302_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","volume":"14","author":"M Aldenhoven","year":"2008","unstructured":"Aldenhoven M, Boelens JJ, de Koning TJ (2008) The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 14:485\u2013498","journal-title":"Biol Blood Marrow Transplant"},{"key":"9302_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4615-0123-7_12","volume":"513","author":"C Alzheimer","year":"2002","unstructured":"Alzheimer C, Werner S (2002) Fibroblast growth factors and neuroprotection. Adv Exp Med Biol 513:335\u2013351","journal-title":"Adv Exp Med Biol"},{"key":"9302_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","volume":"51","author":"JL Ashworth","year":"2006","unstructured":"Ashworth JL, Biswas S, Wraith E, Lloyd IC (2006) Mucopolysaccharidoses and the eye. Surv Ophthalmol 51:1\u201317","journal-title":"Surv Ophthalmol"},{"key":"9302_CR4","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1371\/journal.pone.0002296","volume":"3","author":"J Ausseil","year":"2008","unstructured":"Ausseil J, Desmaris N, Bigou S, Attali R, Corbineau S, Vitry S, Parent M, Cheillan D, Fuller M, Maire I, Vanier MT, Heard JM (2008) Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLoS One 3:e2296","journal-title":"PLoS One"},{"key":"9302_CR5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","volume":"28","author":"F Baehner","year":"2005","unstructured":"Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlsch\u00fctter A, Kampmann C, Beck M (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011\u20131017","journal-title":"J Inherit Metab Dis"},{"key":"9302_CR6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","volume":"1793","author":"A Ballabio","year":"2009","unstructured":"Ballabio A, Gieselmann V (2009) Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta 1793:684\u2013696","journal-title":"Biochim Biophys Acta"},{"key":"9302_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-4165(83)90225-8","volume":"761","author":"J Baumk\u00f6tter","year":"1983","unstructured":"Baumk\u00f6tter J, Cantz M (1983) Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds. Biochim Biophys Acta 761:163\u2013170","journal-title":"Biochim Biophys Acta"},{"key":"9302_CR8","first-page":"782","volume":"87","author":"H Ben Turkia","year":"2009","unstructured":"Ben Turkia H, Tebib N, Azzouz H, Abdelmoula MS, Ben Chehida A, Chemli J, Monastiri K, Chaabouni M, Sanhagi H, Zouari B, Kaabachi N, Ben Dridi MF (2009) Incidence of mucopolysaccharidoses in Tunisia. Tunis Med 87:782\u2013785","journal-title":"Tunis Med"},{"key":"9302_CR9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","volume":"446","author":"JR Bishop","year":"2007","unstructured":"Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030\u20131037","journal-title":"Nature"},{"key":"9302_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2000-7495","volume":"31","author":"R Boor","year":"2000","unstructured":"Boor R, Miebach E, Br\u00fchl K, Beck M (2000) Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 31:122\u2013127","journal-title":"Neuropediatrics"},{"key":"9302_CR11","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1038\/onc.2008.310","volume":"27","author":"P Boya","year":"2008","unstructured":"Boya P, Kroemer G (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27:6434\u20136451","journal-title":"Oncogene"},{"key":"9302_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-007-0296-4","volume":"115","author":"JA Castaneda","year":"2008","unstructured":"Castaneda JA, Lim MJ, Cooper JD, Pearce DA (2008) Immune system irregularities in lysosomal storage disorders. Acta Neuropathol 115:159\u2013174","journal-title":"Acta Neuropathol"},{"key":"9302_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399408000550","volume":"10","author":"LA Clarke","year":"2008","unstructured":"Clarke LA (2008) The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med 10:1\u201318","journal-title":"Expert Rev Mol Med"},{"key":"9302_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","volume":"6","author":"MH Ru de","year":"2011","unstructured":"de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, Mengel E, Offringa M, O\u2019Meara A, Parini R, Rovelli A, Sykora KW, Valayannopoulos V, Vellodi A, Wynn RF, Wijburg FA (2011) Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 6:55","journal-title":"Orphanet J Rare Dis"},{"key":"9302_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.20150","volume":"56","author":"N Desmaris","year":"2004","unstructured":"Desmaris N, Verot L, Puech JP, Caillaud C, Vanier MT, Heard JM (2004) Prevention of neuropathology in the mouse model of Hurler syndrome. Ann Neurol 56:68\u201376","journal-title":"Ann Neurol"},{"key":"9302_CR16","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s10439-008-9575-z","volume":"36","author":"K Forsten-Williams","year":"2008","unstructured":"Forsten-Williams K, Chu CL, Fannon M, Buczek-Thomas JA, Nugent MA (2008) Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng 36:2134\u20132148","journal-title":"Ann Biomed Eng"},{"key":"9302_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20515","volume":"125A","author":"O Gabrielli","year":"2004","unstructured":"Gabrielli O, Polonara G, Regnicolo L, Petroni V, Scarabino T, Coppa GV, Salvolini U (2004) Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet A 125A:224\u2013231","journal-title":"Am J Med Genet A"},{"key":"9302_CR18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1042\/BST0340438","volume":"34","author":"JT Gallagher","year":"2006","unstructured":"Gallagher JT (2006) Multiprotein signalling complexes: regional assembly on heparin sulphate. Biochem Soc Trans 34:438\u2013441","journal-title":"Biochem Soc Trans"},{"key":"9302_CR19","first-page":"107","volume-title":"Lysosomal storage diseases: early diagnosis and new treatments","author":"C Giussani","year":"2010","unstructured":"Giussani C, Miori S, Sganzerla EP (2010) Neurological complications and their management in Mucopolysaccharidosis. In: Parini R, Andria G (eds) Lysosomal storage diseases: early diagnosis and new treatments. John Libbey Eurotext, Montrouge (France), pp 107\u2013120"},{"key":"9302_CR20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/nbm.833","volume":"16","author":"M Hochuli","year":"2003","unstructured":"Hochuli M, W\u00fcthrich K, Steinmann B (2003) Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. NMR Biomed 16:224\u2013236","journal-title":"NMR Biomed"},{"key":"9302_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-2005-872810","volume":"36","author":"B Hoffmann","year":"2005","unstructured":"Hoffmann B, Mayatepek E (2005) Neurological manifestations in lysosomal storage disorders-from pathology to first therapeutic possibilities. Neuropediatrics 36:285\u2013289","journal-title":"Neuropediatrics"},{"key":"9302_CR22","doi-asserted-by":"crossref","first-page":"37515","DOI":"10.1074\/jbc.M111.287474","volume":"286","author":"RJ Holley","year":"2011","unstructured":"Holley RJ, Deligny A, Wei W, Watson HA, Ni\u00f1onuevo MR, Dag\u00e4lv A, Leary JA, Bigger BW, Kjell\u00e9n L, Merry CL (2011) Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking \u03b1-l-iduronidase. J Biol Chem 286:37515\u201337524","journal-title":"J Biol Chem"},{"key":"9302_CR23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1113\/jphysiol.2006.124719","volume":"578","author":"TJ Jentsch","year":"2007","unstructured":"Jentsch TJ (2007) Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. J Physiol 578:633\u2013640","journal-title":"J Physiol"},{"key":"9302_CR24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak M, Futerman AH (2005) Gaucher disease: pathological mechanisms and modern management. Br J Haematol 129:178\u2013188","journal-title":"Br J Haematol"},{"key":"9302_CR25","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.168.10.5233","volume":"168","author":"GB Johnson","year":"2002","unstructured":"Johnson GB, Brunn GJ, Kodaira Y, Platt JL (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168:5233\u20135239","journal-title":"J Immunol"},{"key":"9302_CR26","doi-asserted-by":"crossref","first-page":"C1387","DOI":"10.1152\/ajpcell.00346.2007","volume":"294","author":"SA Khan","year":"2008","unstructured":"Khan SA, Nelson MS, Pan C, Gaffney PM, Gupta P (2008) Endogenous heparan sulphate and heparin modulate bone morphogenetic protein-4 (BMP-4) signalling and activity. Am J Physiol Cell Physiol 294:C1387\u2013C1397","journal-title":"Am J Physiol Cell Physiol"},{"key":"9302_CR27","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1021\/bi960125+","volume":"35","author":"A Krufka","year":"1996","unstructured":"Krufka A, Guimond S, Rapraeger AC (1996) Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding\/receptor transphosphorylation. Biochemistry 35:11131\u201311141","journal-title":"Biochemistry"},{"key":"9302_CR28","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1091\/mbc.E10-04-0348","volume":"21","author":"WJ Kuo","year":"2010","unstructured":"Kuo WJ, Digman MA, Lander AD (2010) Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization. Mol Biol Cell 21:4028\u20134041","journal-title":"Mol Biol Cell"},{"key":"9302_CR29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10278","volume":"69","author":"HH Li","year":"2002","unstructured":"Li HH, Zhao HZ, Neufeld EF, Cai Y, G\u00f3mez-Pinilla F (2002) Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res 69:30\u201338","journal-title":"J Neurosci Res"},{"key":"9302_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/mgme.2000.3139","volume":"72","author":"SS Liour","year":"2001","unstructured":"Liour SS, Jones MZ, Suzuki M, Bieberich E, Yu RK (2001) Metabolic studies of glycosphingolipid accumulation in mucopolysaccharidosis IIID. Mol Genet Metab 72:239\u2013247","journal-title":"Mol Genet Metab"},{"key":"9302_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","volume":"11","author":"Y Liu","year":"2005","unstructured":"Liu Y, Xu L, Hennig AK, Kovacs A, Fu A, Chung S, Lee D, Wang B, Herati RS, Mosinger Ogilvie J, Cai SR, Parker Ponder K (2005) Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Mol Ther 11:35\u201347","journal-title":"Mol Ther"},{"key":"9302_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00206770","volume":"85","author":"RB Lowry","year":"1990","unstructured":"Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY (1990) An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 85:389\u2013390","journal-title":"Hum Genet"},{"key":"9302_CR33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1651-2227.2008.00965.x","volume":"97","author":"G Malm","year":"2008","unstructured":"Malm G, Lund AM, M\u00e5nsson JE, Heiberg A (2008) Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr 97:1577\u20131581","journal-title":"Acta Paediatr"},{"key":"9302_CR34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00234-004-1215-1","volume":"46","author":"MG Matheus","year":"2004","unstructured":"Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J (2004) Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46:666\u2013672","journal-title":"Neuroradiology"},{"key":"9302_CR35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","volume":"480","author":"R McGlynn","year":"2004","unstructured":"McGlynn R, Dobrenis K, Walkley SU (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480:415\u2013426","journal-title":"J Comp Neurol"},{"key":"9302_CR36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249\u2013254","journal-title":"JAMA"},{"key":"9302_CR37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.33588\/rn.4909.2009170","volume":"49","author":"C Men\u00e9ndez-Sainz","year":"2009","unstructured":"Men\u00e9ndez-Sainz C, Gonz\u00e1lez-Garc\u00eda S, Pe\u00f1a-S\u00e1nchez M, Zald\u00edvar-Mu\u00f1oz C, Gonz\u00e1lez-Quevedo A (2009) Mucopolisacaridosis: diagn\u00f3stico enzim\u00e1tico de 20 a\u00f1os en Cuba. Rev Neurol 49:458\u2013462","journal-title":"Rev Neurol"},{"key":"9302_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcp.1080","volume":"187","author":"K Miyazono","year":"2001","unstructured":"Miyazono K, Kusanagi K, Inoue H (2001) Divergence and convergence of TGF-beta\/BMP signaling. J Cell Physiol 187:265\u2013276","journal-title":"J Cell Physiol"},{"key":"9302_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","volume":"3","author":"D Moore","year":"2008","unstructured":"Moore D, Connock MJ, Wraith E, Lavery C (2008) The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis 3:24","journal-title":"Orphanet J Rare Dis"},{"key":"9302_CR40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/BST0340409","volume":"34","author":"B Mulloy","year":"2006","unstructured":"Mulloy B, Rider CC (2006) Cytokines and proteoglycans: an introductory overview. Biochem Soc Trans 34:409\u2013413","journal-title":"Biochem Soc Trans"},{"key":"9302_CR41","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3421\u20133452","edition":"8"},{"key":"9302_CR42","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A 100:1902\u20131907","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9302_CR43","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2005-02-0657","volume":"106","author":"C Pan","year":"2005","unstructured":"Pan C, Nelson MS, Reyes M, Koodie L, Brazil JJ, Stephenson EJ, Zhao RC, Peters C, Selleck SB, Stringer SE, Gupta P (2005) Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. Blood 106:1956\u20131964","journal-title":"Blood"},{"key":"9302_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nri1918","volume":"6","author":"CR Parish","year":"2006","unstructured":"Parish CR (2006) The role of heparan sulphate in inflammation. Nat Rev Immunol 6:633\u2013643","journal-title":"Nat Rev Immunol"},{"key":"9302_CR45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1152\/physiol.00041.2009","volume":"25","author":"EJ Parkinson-Lawrence","year":"2010","unstructured":"Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace GN, Brooks DA (2010) Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) 25:102\u2013115","journal-title":"Physiology (Bethesda)"},{"key":"9302_CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2007.09.008","volume":"387","author":"VG Pereira","year":"2008","unstructured":"Pereira VG, Martins AM, Micheletti C, D\u2019Almeida V (2008) Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy. Clin Chim Acta 387:75\u201379","journal-title":"Clin Chim Acta"},{"key":"9302_CR47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcp.22039","volume":"223","author":"VG Pereira","year":"2010","unstructured":"Pereira VG, Gazarini ML, Rodrigues LC, da Silva FH, Han SW, Martins AM, Tersariol IL, D\u2019Almeida V (2010) Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis. J Cell Physiol 223:335\u2013342","journal-title":"J Cell Physiol"},{"key":"9302_CR48","doi-asserted-by":"crossref","first-page":"28554","DOI":"10.1074\/jbc.M111754200","volume":"277","author":"AK Powell","year":"2002","unstructured":"Powell AK, Fernig DG, Turnbull JE (2002) Fibroblast growth factor receptors 1 and 2 interact differently with heparin\/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex. J Biol Chem 277:28554\u201328563","journal-title":"J Biol Chem"},{"key":"9302_CR49","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s11064-010-0380-3","volume":"36","author":"A Prinetti","year":"2011","unstructured":"Prinetti A, Prioni S, Chiricozzi E, Schuchman EH, Chigorno V, Sonnino S (2011) Secondary alterations of sphingolipid metabolism in lysosomal storage diseases. Neurochem Res 36:1654\u20131668","journal-title":"Neurochem Res"},{"key":"9302_CR50","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.149.5.1053","volume":"149","author":"PR Pryor","year":"2000","unstructured":"Pryor PR, Mullock BM, Bright NA, Gray SR, Luzio JP (2000) The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J Cell Biol 149:1053\u20131062","journal-title":"J Cell Biol"},{"key":"9302_CR51","doi-asserted-by":"crossref","first-page":"22936","DOI":"10.1074\/jbc.273.36.22936","volume":"273","author":"DA Pye","year":"1998","unstructured":"Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT (1998) Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 273:22936\u201322942","journal-title":"J Biol Chem"},{"key":"9302_CR52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10571-008-9335-5","volume":"29","author":"GK Reolon","year":"2009","unstructured":"Reolon GK, Reinke A, de Oliveira MR, Braga LM, Camassola M, Andrades ME, Moreira JC, Nardi NB, Roesler R, Dal-Pizzol F (2009) Alterations in oxidative markers in the cerebellum and peripheral organs in MPS I mice. Cell Mol Neurobiol 29:443\u2013448","journal-title":"Cell Mol Neurobiol"},{"key":"9302_CR53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0046-8177(94)90200-3","volume":"25","author":"JM Resnick","year":"1994","unstructured":"Resnick JM, Whitley CB, Leonard AS, Krivit W, Snover DC (1994) Light and electron microscopic features of the liver in mucopolysaccharidosis. Hum Pathol 25:276\u2013286","journal-title":"Hum Pathol"},{"key":"9302_CR54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00247-008-0788-y","volume":"38","author":"RG Schumacher","year":"2008","unstructured":"Schumacher RG, Brzezinska R, Schulze-Frenking G, Pitz S (2008) Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI. Pediatr Radiol 38:543\u2013550","journal-title":"Pediatr Radiol"},{"key":"9302_CR55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","volume":"57","author":"CM Simonaro","year":"2005","unstructured":"Simonaro CM, D\u2019Angelo M, Haskins ME, Schuchman EH (2005) Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res 57:701\u2013707","journal-title":"Pediatr Res"},{"key":"9302_CR56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","volume":"172","author":"CM Simonaro","year":"2008","unstructured":"Simonaro CM, D\u2019Angelo M, He X, Eliyahu E, Shtraizent N, Haskins ME, Schuchman EH (2008) Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 172:112\u2013122","journal-title":"Am J Pathol"},{"key":"9302_CR57","doi-asserted-by":"crossref","DOI":"10.1201\/9781420028256","volume-title":"Oxidative stress, inflammation, and health","author":"YJ Surh","year":"2005","unstructured":"Surh YJ, Packer L (2005) Oxidative stress, inflammation, and health. Taylor and Francis, London"},{"key":"9302_CR58","doi-asserted-by":"crossref","first-page":"43229","DOI":"10.1074\/jbc.M300937200","volume":"278","author":"T Takada","year":"2003","unstructured":"Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R (2003) Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278:43229\u201343235","journal-title":"J Biol Chem"},{"key":"9302_CR59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.GIM.0000078027.83236.49","volume":"5","author":"NJ Terlato","year":"2003","unstructured":"Terlato NJ, Cox GF (2003) Can mucopolysaccharidosis type I disease severity be predicted based on a patient\u2019s genotype? A comprehensive review of the literature. Genet Med 5:286\u2013294","journal-title":"Genet Med"},{"key":"9302_CR60","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/15216540600904885","volume":"58","author":"A Terman","year":"2006","unstructured":"Terman A, Kurz T, Gustafsson B, Brunk UT (2006) Lysosomal labilization. IUBMB Life 58:531\u2013539","journal-title":"IUBMB Life"},{"key":"9302_CR61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10545-005-0069-y","volume":"28","author":"S Tomatsu","year":"2005","unstructured":"Tomatsu S, Gutierrez MA, Ishimaru T, Pe\u00f1a OM, Monta\u00f1o AM, Maeda H, Velez-Castrillon S, Nishioka T, Fachel AA, Cooper A, Thornley M, Wraith E, Barrera LA, Laybauer LS, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Noguchi A (2005) Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis 28:743\u2013757","journal-title":"J Inherit Metab Dis"},{"key":"9302_CR62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2009.10.001","volume":"99","author":"S Tomatsu","year":"2010","unstructured":"Tomatsu S, Monta\u00f1o AM, Oguma T, Dung VC, Oikawa H, Guti\u00e9rrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Barrera LA, Kida K, Kubota M, Orii T (2010) Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry. Mol Genet Metab 99:124\u2013131","journal-title":"Mol Genet Metab"},{"key":"9302_CR63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jnr.21134","volume":"85","author":"GR Villani","year":"2007","unstructured":"Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez Y, Reyero E, Di Natale P (2007) Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 85:612\u2013622","journal-title":"J Neurosci Res"},{"key":"9302_CR64","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","volume":"285","author":"EB Vitner","year":"2010","unstructured":"Vitner EB, Platt FM, Futerman AH (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285:20423\u201320427","journal-title":"J Biol Chem"},{"key":"9302_CR65","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1098\/rstb.2003.1276","volume":"358","author":"SU Walkley","year":"2003","unstructured":"Walkley SU (2003) Neurobiology and cellular pathogenesis of glycolipid storage diseases. Philos Trans R Soc Lond B 358:893\u2013904","journal-title":"Philos Trans R Soc Lond B"},{"key":"9302_CR66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","volume":"15","author":"SU Walkley","year":"2004","unstructured":"Walkley SU (2004a) Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol 15:433\u2013444","journal-title":"Semin Cell Dev Biol"},{"key":"9302_CR67","first-page":"32","volume-title":"Lysosomal disorders of the brain","author":"SU Walkley","year":"2004","unstructured":"Walkley SU (2004b) Pathogenic cascades and brain dysfunction. In: Platt FM, Walkley SU (eds) Lysosomal disorders of the brain. Oxford University Press, Oxford, pp 32\u201349"},{"key":"9302_CR68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","volume":"32","author":"SU Walkley","year":"2009","unstructured":"Walkley SU (2009) Pathogenic cascades in lysosomal disease-Why so complex? J Inherit Metab Dis 32:181\u2013189","journal-title":"J Inherit Metab Dis"},{"key":"9302_CR69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2007.00202.x","volume":"96","author":"SU Walkley","year":"2007","unstructured":"Walkley SU (2007) Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr Suppl 96:26\u201332","journal-title":"Acta Paediatr Suppl"},{"key":"9302_CR70","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/cercor\/10.10.1028","volume":"10","author":"SU Walkley","year":"2000","unstructured":"Walkley SU, Zervas M, Wiseman S (2000) Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons. Cereb Cortex 10:1028\u20131037","journal-title":"Cereb Cortex"},{"key":"9302_CR71","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/nen.0b013e31812571c8","volume":"66","author":"RM Walton","year":"2007","unstructured":"Walton RM, Wolfe JH (2007) Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease. J Neuropathol Exp Neurol 66:760\u2013769","journal-title":"J Neuropathol Exp Neurol"},{"key":"9302_CR72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","volume":"99","author":"D Wang","year":"2010","unstructured":"Wang D, Shukla C, Liu X, Schoeb TR, Clarke LA, Bedwell DM, Keeling KM (2010) Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Mol Genet Metab 99:62\u201371","journal-title":"Mol Genet Metab"},{"key":"9302_CR73","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0883073807300528","volume":"22","author":"A Yuen","year":"2007","unstructured":"Yuen A, Dowling G, Johnstone B, Kornberg A, Coombs C (2007) Carpal tunnel syndrome in children with mucopolysaccharidoses. J Child Neurol 22:260\u2013263","journal-title":"J Child Neurol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-012-9302-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-012-9302-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-012-9302-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:24:03Z","timestamp":1742934243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-012-9302-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,14]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9302"],"URL":"https:\/\/doi.org\/10.1007\/s11011-012-9302-1","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,14]]}}}